Rare Cell Isolation Market Size, Share & Trends Report

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells), By Technology, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-359-9
Number of Report Pages: 120
Format: PDF

Historical Range: 2018 - 2023
Forecast Period: 2024 - 2030
Industry: Healthcare

Market Segmentation

Rare Cell Isolation Product Outlook (Revenue, USD Million, 2018 - 2030)
- Reagent & Kits
- Instrument
Rare Cell Isolation Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
- Circulating Tumor Cells
- Stem Cells
- Fetal Cells
- Rare Immune Cells
- Circulating Endothelial Cells
- Other Rare Cell Types
Rare Cell Isolation Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Magnetic Bead Separation
- Fluorescence-Activated Cell Sorting
- Microfluidics-based techniques
Rare Cell Isolation Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent & Kits
    - Instrument
  - North America Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Circulating Tumor Cells
    - Stem Cells
    - Fetal Cells
    - Rare Immune Cells
    - Circulating Endothelial Cells
    - Other Rare Cell Types
  - North America Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Magnetic Bead Separation
    - Fluorescence-Activated Cell Sorting
    - Microfluidics-based techniques
  - U.S.
    - U.S. Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - U.S. Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - U.S. Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Canada
    - Canada Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Canada Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Canada Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Mexico
    - Mexico Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Mexico Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Mexico Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
- Europe
  - Europe Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent & Kits
    - Instrument
  - Europe Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Circulating Tumor Cells
    - Stem Cells
    - Fetal Cells
    - Rare Immune Cells
    - Circulating Endothelial Cells
    - Other Rare Cell Types
  - Europe Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Magnetic Bead Separation
    - Fluorescence-Activated Cell Sorting
    - Microfluidics-based techniques
  - UK
    - UK Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - UK Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - UK Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Germany
    - Germany Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Germany Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Germany Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - France
    - France Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - France Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - France Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Italy
    - Italy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Italy Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Italy Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Spain
    - Spain Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Spain Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Spain Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Denmark
    - Denmark Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Denmark Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Denmark Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Sweden
    - Sweden Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Sweden Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Sweden Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Norway
    - Norway Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Norway Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Norway Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
- Asia Pacific
  - Asia Pacific Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent & Kits
    - Instrument
  - Asia Pacific Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Circulating Tumor Cells
    - Stem Cells
    - Fetal Cells
    - Rare Immune Cells
    - Circulating Endothelial Cells
    - Other Rare Cell Types
  - Asia Pacific Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Magnetic Bead Separation
    - Fluorescence-Activated Cell Sorting
    - Microfluidics-based techniques
  - Japan
    - Japan Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Japan Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Japan Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - China
    - China Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - China Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - China Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - India
    - India Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - India Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - India Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - South Korea
    - South Korea Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - South Korea Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - South Korea Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Australia
    - Australia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Australia Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Australia Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Thailand
    - Thailand Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Thailand Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Thailand Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
- Latin America
  - Latin America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent & Kits
    - Instrument
  - Latin America Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Circulating Tumor Cells
    - Stem Cells
    - Fetal Cells
    - Rare Immune Cells
    - Circulating Endothelial Cells
    - Other Rare Cell Types
  - Latin America Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Magnetic Bead Separation
    - Fluorescence-Activated Cell Sorting
    - Microfluidics-based techniques
  - Brazil
    - Brazil Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Brazil Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Brazil Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Argentina
    - Argentina Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Argentina Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Argentina Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
- MEA
  - MEA Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent & Kits
    - Instrument
  - MEA Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Circulating Tumor Cells
    - Stem Cells
    - Fetal Cells
    - Rare Immune Cells
    - Circulating Endothelial Cells
    - Other Rare Cell Types
  - MEA Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Magnetic Bead Separation
    - Fluorescence-Activated Cell Sorting
    - Microfluidics-based techniques
  - South Africa
    - South Africa Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - South Africa Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - South Africa Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Saudi Arabia
    - Saudi Arabia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Saudi Arabia Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Saudi Arabia Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - UAE
    - UAE Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - UAE Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - UAE Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques
  - Kuwait
    - Kuwait Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent & Kits
      - Instrument
    - Kuwait Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Circulating Tumor Cells
      - Stem Cells
      - Fetal Cells
      - Rare Immune Cells
      - Circulating Endothelial Cells
      - Other Rare Cell Types
    - Kuwait Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Magnetic Bead Separation
      - Fluorescence-Activated Cell Sorting
      - Microfluidics-based techniques

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.